And ranibizumab (Lucentis®, Genentech, Inc.), a Fab fragment similar to Bevacizumab, has been also approved for the treatment of wet AMD [11].VEGF Trap (aflibercept, Regeneron Pharmaceuticals, Inc.)is a novel soluble decoy receptor generated with Trap technology. The gene discussed is VEGFA; the disease is wet macular degeneration.